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Abstract: To intoxicate cells, pore-forming bacterial toxins are evolved to allow for the 
transmembrane traffic of different substrates, ranging from small inorganic ions to  
cell-specific polypeptides. Recent developments in single-channel electrical recordings,  
X-ray crystallography, protein engineering, and computational methods have generated a 
large body of knowledge about the basic principles of channel-mediated molecular 
transport. These discoveries provide a robust framework for expansion of the described 
principles and methods toward use of biological nanopores in the growing field of 
nanobiotechnology. This article, written for a special volume on ―Intracellular Traffic  
and Transport of Bacterial Protein Toxins‖, reviews the current state of applications of  
pore-forming bacterial toxins in small- and macromolecule-sensing, targeted cancer 
therapy, and drug delivery. We discuss the electrophysiological studies that explore 
molecular details of channel-facilitated protein and polymer transport across cellular 
membranes using both natural and foreign substrates. The review focuses on the 
structurally and functionally different bacterial toxins: gramicidin A of Bacillus brevis,  
α-hemolysin of Staphylococcus aureus, and binary toxin of Bacillus anthracis, which have 
found their ―second life‖ in a variety of developing medical and technological applications. 
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1. Introduction: Channel-Forming Bacterial Toxins 
During intoxication or internalization, many bacterial exotoxins form ion-conducting channels in 
membranes of the targeted cells or intracellular organelles. Channel formation is potentiated by a 
unique ability of many of these molecules to exist in two states: a stable water-soluble conformation 
and an integral membrane pore [1]. The resulting channels contribute to the toxin’s virulent action 
either directly or indirectly. Some channel-forming toxins directly kill compromised cells by inducing 
uncontrollable leaks of ions, water, and/or water-soluble metabolites [2–4]. The toxin-induced 
membrane perforation allows virulent cells to combat the host defense systems, to mediate escape of 
invasive bacterial cells into host cytoplasm from encapsulating phagosomes, to provide nutrients for 
bacteria, and to eliminate or control the competing bacterial cells [4–8]. Membrane-perforating 
bacterial toxins are often called pore-forming toxins (PFTs). 
Distinctively different are the AB-type toxins that employ channel-forming parts for intracellular 
delivery of specialized catalytic subunits. In contrast to PFTs, AB-type toxins act in the cytosol, 
targeting specific intracellular substrates. The AB-type toxins are secreted as either single-chain 
proteins containing at least two functional domains, the receptor binding B domain and the 
active/enzymatic A domain, or as two (or three in the case of anthrax toxin) individual non-linked 
binary toxin subunits, an enzymatic/active A component and a binding/translocation B component [9]. 
For the AB-type toxin intracellular action, the enzymatic A component has to be delivered across the 
target cell membrane into the cytosol. Remarkably, the B components of the binary bacterial toxins 
secreted by several pathogenic species of Bacillus and Clostridium not only provide the binding site 
for the A components but also mediate the A component intracellular transport [9]. In particular, 
following the receptor mediated endocytosis, the B components form oligomeric transmembrane 
channels, that have been suggested to serve as active translocation pathways for the A component 
transport. The exact role of the B domain in transport of the single-chain AB-type toxins is debated; in 
particular, it is not always established whether the uptake of these toxins involves formation of ion 
channels. However, ion channel activity in planar bilayer membranes has been documented for at least 
two members of the family, namely diphtheria toxin, DT of Corynebacterium diphtheriae [10–12] and 
botulinum neurotoxin, BoNT of Clostridium botulinum [13,14]. Moreover, even though formation of 
ion channels in the artificial lipid bilayer systems has been reported for a number of binary bacterial 
toxin B components [15–17], the traditional pore-facilitated model of anthrax toxin internalization was 
recently challenged by an alternative ―membrane rupturing‖ scenario [18]. 
This review is written to discuss several ―classical‖ channel-forming bacterial toxins, which won 
their ―second life‖ in a variety of developing biotechnological applications. Because the focus of this 
―Toxins‖ issue is on intracellular traffic and transport of bacterial protein toxins, we will mostly 
discuss the questions related to biosensing properties of the channel-forming bacterial toxins.  
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More specifically, we highlight the applications where bacterial toxin pores were used to probe 
mechanisms of molecule detection and macromolecule transport. Remarkably, some of these 
applications, for instance those that develop the targeted toxin therapies to battle cancer, directly 
employ the unique ability of these proteins to intoxicate cells, whereas many other approaches use the 
channel-forming bacterial toxins as suitable tools able to respond to electrical, chemical or mechanical 
stimuli [19]. Note that the channel-forming proteins play quite distinct roles in the cell intoxication by 
PFTs and AB-type bacterial toxins. However, for the practical purpose of this review, we will use the 
term ―channel-forming bacterial toxins‖ when referring to any of these types of toxins. 
2. Biosensing and Polymer Translocation with Nanopores  
The channel-forming toxins, and, more broadly, biological nanopores are molecules of immediate 
interest for biotechnology [19–22]. The ability of these molecules to generate selective and regulated 
pathways for water, ions, and water-soluble small and macromolecules in biological and artificial 
membranes offers exciting possibilities for a variety of medical and technological applications. To be 
directly examined for these applications, the biological nanopores are often incorporated into model 
lipid membranes where changes in the channel permeability to ions could be detected directly by 
applying transmembrane voltage and measuring ion current. The reconstitution methods range from 
the ―classical‖ planar lipid bilayer and liposomes-based approaches to membranes supported on solid 
substrates and droplet interface bilayers (reviewed in refs. [19,23]). After gaining momentum from the 
pioneered studies by Kasianowicz and Bezrukov [24,25] where α-hemolysin (αHL) of Staphylococcus 
aureus was suggested to serve as a ―nanoscopic cuvette‖ to study reaction dynamic some 20 years ago, 
the field rapidly exploded. Sensing with biological nanopores is based on reversible interruptions of ion 
current through an assembled pore in the model membrane that are generated by individual analytes, 
molecular complexes or nanoscale objects. Changes in this current resolved with uttermost precision 
using low noise feedback-loop operational amplifiers [26] could be used to determine presence, identity, 
structure, sequence, charged state, and kinetics of the studied objects or phenomena. In a way, this 
method is a molecular-scaled version of the resistive-pulse sensing technique suggested by William Coulter 
to count particles suspended in a fluid [27]. Within the reconstituted pore, single molecule binding affects 




 of the small ions, thus providing great electrical 
amplification of the studied single-molecule process. Pores formed by the membrane-perforating toxins 
may act as elementary on/off ―switches‖ activated in response to interaction with specific analyte 
molecules, and as sensors reporting on their membrane surrounding and providing a specific volume 
for the studied compounds to pass and/or to interact.  
3. GrA, αHL, and PA63 as Nanopores of Choice in Biotechnology  
Among a variety of channel-forming bacterial toxins potentially suitable for the biotechnological 
applications, one can highlight several dominant toxin molecules that, for a number of reasons, are in 
the lead of the field. Those are small peptide channel-forming gramicidin A of Bacillus brevis, which 
induces lesions in cell membranes; α-hemolysin of Staphylococcus aureus, a β-barrel heptameric  
pore-former, which also perforates cellular membranes; and binary toxin of Bacillus anthracis,  
in which the channel-forming component mediates delivery of the enzymatic subunits into target cell 
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cytoplasm. The small channel-forming peptides, such as gramicidin A, can be chemically modified to 
serve as ideal on/off switches reacting to different stimuli and sensors of the bilayer membrane 
physical properties. The large -barrel channels, such as α-hemolysin, are more suitable for the 
stochastic resistive-pulse sensing of the entering or passing small and macromolecules. The binary 
anthrax toxin is a unique tool to investigate the fundamental principles of protein translocation 
across the membranes and to reengineer the toxin’s properties for targeted killing of the cancer cells. 
In the following sections, we will first briefly review the biological functions of gramicidin A,  
α-hemolysin, and anthrax toxin and then discuss the main current and potential future applications of 
these three toxins in the growing field of biotechnology.  
3.1. Gramicidin A of Bacillus Brevis 
Antibiotic gramicidin A (GrA) is secreted by soil bacteria Bacillus brevis in a mixture containing 
closely related peptide compounds [28]. GrA, which is a linear pentadecapeptide composed of 15 
alternating L-D amino acids [29–31], is active against many gram-positive and several gram-negative 
bacteria [32]. Arguably one of the first ever described pore-formers, GrA generates defined and 
reproducible transmembrane water-filled channels [33] (Figure 1). 
Figure 1. (a) Side and end views of the bilayer-spanning gramicidin A (GrA) channel.  
The energy-minimized structure represents a composite consistent with several NMR  
structures (PDB 1GRM, 1MAG); (b) GrA channels formed by the transbilayer 
dimerization of two β-helical subunits; (c) Single-channel current trace obtained with  
GrA in diphytanoylphosphatidylcholine bilayer [34]. Reprinted and modified with 
permission from reference [34]. 
 
GrA membrane activity has been studied extensively over the last 40 years. Solution and solid-state 
NMR reveals a dimeric structure of the GrA pore where each molecular monomer adopts β-helical 
conformation and interacts with another one through hydrogen bonding between terminal formyl 
groups [35,36]. The luminal diameter of the pore that is formed by a peptide backbone is 4 Å, as 
determined from the channel’s permeability to alkali metal cations, H
+
, and water [37,38] (Figure 1a). 
Despite relatively low molecular weight of ~2 kDa, GrA creates well-defined and reproducible pores 
in planar lipid membranes (Figure 1c). The presented ion current recording, obtained under  
voltage-clamp experimental conditions, demonstrates sharp step-wise increments of the transmembrane 
current, where each upward ―step‖ corresponds to formation of a GrA conductive dimer in a 
membrane, and the downward step indicates the dimer dissociation; maximum of four concurrently 
 
a b c 
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open GrA channels are seen in the record (numbered on the right side of Figure 1c). This type of 
single-channel recording allows for direct estimation of the major parameters of ion channel activity, 
current amplitude of the single pore and its average open time. These channels exhibit the structural 
and functional features typical for complex membrane proteins: defined conductive levels, sharp 
transitions between open and closed states (i.e., spontaneous gating), and low excess electric noise of 
the pore open state. The gramicidin channels show an ideal selectivity for monovalent inorganic 
cations [38], that originates from the side chain dipoles of the peptide backbone facing the channel 
lumen [39,40]. The cation transport across the narrow GrA pore occurs in a single-file fashion through 
consecutive ion bindings to two specific sites in the pore [41]. 
The gramicidin channels are specifically interesting because they show a unique sensitivity to the 
properties of the surrounding lipid bilayer. The length of a pore-forming dimer is only ~26 Å, which 
roughly matches the thickness of the hydrophobic part of the lipid bilayer. Since the hydrophobic 
thickness of the gramicidin dimer is less than the thickness of the membrane [42,43], pore formation is 
almost always associated with a local membrane deformation [44,45] (Figure 1b). The energetic cost 
of that deformation is therefore a primary factor determining the channel’s functions. Because of that, 
the membrane lipid environment is a strong modulator of the GrA channel activity. Subtle changes in 
membrane properties such as membrane thickness, lipid composition, and ordered state influence 
parameters of GrA channels. Due to its relative simplicity, gramicidin has been recognized as unique 
ion channel for modeling and simulation of the fundamental principles of lipid/protein interactions, 
and membrane protein structure and function. The GrA channels are good candidates for the molecular 
sensing applications because of the relative simplicity of the peptide, defined characteristics of the ion 
channel conductance, and unique sensitivity of conductive parameters channel to the membrane 
structure [46,47]. In the developed applications, GrA is used to study mechanical properties [48] and 
charged state of membranes [34,49,50], to detect protein-membrane interactions [51], to probe enzyme 
activity [52] and protein-protein interactions, to create conductive components of bio-inspired  
diodes [53], and to fabricate components of drug delivery systems in nanomedicine [54]. 
3.2. α-Hemolysin of Staphylococcus Aureus 
Alpha-hemolysin (αHL) is a water-soluble toxin secreted by the pathogenic bacterium 
Staphylococcus aureus [55,56]. Released as a 293-amino acid monomeric polypeptide with a 
molecular mass of 33 kDa, αHL is believed to bind to membrane protein receptors [57,58] and/or to 
specific lipids in the susceptible target cells [59,60]. Seven adsorbed monomeric subunits then 
associate and form a nonlytic prepore complex on the membrane. The subunits further penetrate the 
membrane to form a lytic pore [61,62]. Recent evidence suggests that the lytic pore formation may 
be not the only way of αHL toxicity. A specific toxin-induced activation of its putative 
metalloprotease receptor may trigger activation of intracellular cascades, leading to increased 
toxicity (for a review see reference [63]). However, the correct assembly of the αHL pores remains a 
necessary step for its toxic action [64]. 
The first original study on αHL channel reconstitution in the model bilayers membranes was performed 
by Krasilnikov and co-workers over three decades ago [65]. Further electrophysiological studies 
refined our understanding of an αHL pore’s conductance, geometric, and gating properties [66–77]. 
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The pore is weakly anion-selective at neutral pH [66] and a stable conductance of ~1 nS is observed in 
1 M KCl solution at room temperature (Figure 2a). 
Figure 2. (a) Typical recording of a single αHL channel reconstituted into  
diphytanoyl-phosphatidylcholine membrane. Applied voltage is 100 mV. Channel current 
corresponds to ~100 pA in 1M KCl, pH 7.4; (b) Crystal structure of the αHL heptamer  
(top and side views are shown) (PDB 7AHL) [78]. The mushroom-shaped complex is 
approximately 100 Å tall and up to 100 Å in diameter, and the stem domain measures 
about 52 Å in height and 26 Å in diameter.  
 
Crystal structure of the αHL pore was solved in 1996 at 1.9-Å resolution [78] (Figure 2b). The pore 
heptamer has a hollow mushroom-like shape consisting of the ―stem‖, ―cap‖, and ―rim‖ domains. The 
cap of the mushroom, which together with the rim forms the core of the protein complex, resides 
outside the target membrane and is formed by the N- and C-terminal ends of the monomers; it is 
composed of a β-sandwich and has a diameter of 100 Å. The stem part is a lytic transmembrane  
14-stranded β-barrel assembled from seven β-hairpins, each contributed by an individual monomer. 
Two apparent constrictions with radii of 0.9 nm and 0.6–0.7 nm are located in the channel lumen, with 
the larger one being closer to the side of the cap. The interior of the β-barrel is primarily hydrophilic 
while the exterior has a hydrophobic surface. Molecular dynamic simulations were applied to estimate 
the diameter of the pore and the permeability of water through its side channels of the mushroom 
―head‖ [79]. By applying an electric potential across the pore, the authors were able to calculate the 
open-channel conductivity and the electrostatic potential along the pore length. Large pore dimensions 
and structural robustness of the αHL heptamer permit the wide usage of this bacterial toxin in a variety 
of developing biotechnological applications. 
3.3. PA63 Component of Anthrax Toxin of Bacillus Anthracis 
Bacillus anthracis, the bacterium that causes anthrax, is a large Gram-positive, rod-shaped,  
aerobic, spore-forming bacterial pathogen. The tripartite exotoxin (anthrax toxin) [80,81] and 
phagocytosis-inhibiting poly-D-glutamic acid capsule are the main virulence factors of B. anthracis [82]. 
The deliberate dissemination of B. anthracis spores in 2001 via the ―anthrax letters‖ and their fatal 
consequences led to almost 13 years of continuing political and scientific efforts to develop medical 
countermeasures to protect humans from anthrax bioterrorism [83]. Because anthrax infections are 
infrequent, bacterial resistance of B. anthracis, even though described [84,85], is not a major focus of 
ongoing research. The recent efforts to disable the anthrax infection mostly focused on inhibiting the 
about 52 Å in height and 26 Å in di m ter.  
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tripartite anthrax toxin (reviewed in [86]). Anthrax infection, especially in its inhalational form, is 
extremely difficult to treat because flu-like symptoms appear only after B. anthracis have multiplied 
inside the host and started to produce the anthrax exotoxin [87,88]. At this stage, the aggressive 
antibacterial therapy can inhibit the bacterium growth, but the infection can still be lethal because of 
the accumulation of the toxin [89]. The recent progress made in understanding of anthrax toxin 
structure, arrangement, cellular uptake and functions is significant (reviewed in refs. [90–100]).  
Briefly, the binary anthrax toxin consists of two enzymatically active A moieties: lethal factor (LF) 
and edema factor (EF), and a single shared binding and translocation moiety: protective antigen (PA). 
The term ―protective antigen‖ originates from the ability of this protein to stimulate production of the 
protective antibodies when used in anthrax vaccines. Individually, anthrax toxin’s PA, LF and EF 
components are nontoxic; however, PA combinations with lethal toxin (LT = LF + PA) or with edema 
toxin (ET = EF + PA) are primarily responsible for the anthrax symptoms and lethality. 
The internalization process of anthrax toxin involves several stages (Figure 3a). 
Figure 3. (a) A schematic model of Bacillus anthracis toxins cell entry; (b) Side and top 
views of anthrax toxin PA63 component (the symmetric model, PDB:1V36) [101]. The 
Phe427s are marked because of their importance in the transport properties; (c) Conductance of 
a single PA63 channel reconstituted into planar lipid membranes demonstrate fast flickering 
between open and closed states at 1-ms time resolution [102]. Reprinted with permission 
from references [86,101,102]. Copyright 2011 Wiley, 2012 Elsevier. 
 
First, full length PA83 binds to the CMG2 and TEM8 receptors [103,104] on a host cell surface and 
is subsequently cleaved by extracellular furin protease to PA63 [105]. PA63 then undergoes 
oligomerization, which leads to formation of heptameric, (PA63)7 [106] and octameric, (PA63)8 [107] 
ring-shaped prepores. The formation of (PA63)7 and (PA63)8 generates, correspondingly, three [108] 
and four [107] LF/EF binding sites at the interface of two adjacent PA63 molecules and causes 
receptor-mediated endocytosis of the anthrax toxin tripartite complexes [109]. The oligomeric PA63 
prepore then undergoes significant structural changes promoted by the acidic endosomal environment, 
which results in the formation of a mushroom-shaped ion channel (125 Å in diameter with 70 Å long 
cap, and 100 Å long stem [110]) (Figure 3b), preferentially selective to cations [15]. When 
from refs. [87,102,103]. Copyright 2011 Wiley, 2012 
Elsevier. 
 
First, full length PA83 binds to the CMG2 and TEM8 r ceptors [104,105] on a host cell 
surface  
a b c 
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incorporated into the bilayer lipid membranes, PA63 was reported to form ion-permeable cation-selective 
ion channels [15,111,112] prone to voltage-dependent closures typical for the other -barrel channels. 
The characteristic property of PA63 single channels as well as the channel-forming components of 
binary clostridial C2 and iota toxins reconstituted into bilayer membranes is the non-voltage-dependent 
flickering of ion current between the open and completely closed states [16,17,113–115] (Figure 3c). 
Interestingly, the current noise of the F427A (-clamp) mutant (see Section 5.2) of PA63 is mostly free 
of this complex behavior [115]. A PA oligomer then is believed to act as an effective translocase, 
which unfolds and translocates LF and EF inside the cell using the proton gradient across the 
endosomal membrane (pHendosome < pHcytosol) [116–121]. In an alternative model, the anthrax toxin 
catalyzes rupture of the endosomal membrane and toxic complexes are released into the cytosol [18]. 
Once in the cytosol, LF and EF actuate their catalytic actions. LF is a Zn-metalloprotease that cleaves 
mitogen-activated protein kinase kinases [122,123] and NLrp1 [124], resulting in disturbing host cell 
signal transduction. EF is a calmodulin-dependent adenylyl cyclase, which increases the cAMP level in 
the cells, contributing to dissemination of Bacillus anthracis in the host [125]. The key tissue targets 
responsible for the poisonous effect of LT and ET were recently identified [126]. LT and ET were 
shown to target the cardiovascular system and liver, respectively. 
Anthrax toxin represents a unique arrangement of proteins where intracellular delivery of the 
enzymatic components is governed by the channel-forming component. Therefore, it provides an 
exceptional biological tool to study molecular details of protein transport and to rearm this toxin 
against malignant cells. 
4. Channel Forming Bacterial Toxins for Molecular Sensing 
4.1. Probing Structure, Charge and Physical State of the Membranes with GrA  
The physical properties of biological membranes, namely membrane composition, lipid content, 
and asymmetry in lipid distribution between the bilayer leaflets and prevalence of the charged species 
are among the general factors affecting functions of membrane-embedded proteins. Apart from the specific 
protein/lipid interactions, the effect of the colligative membrane properties such as bilayer thickness, 
viscosity, bending rigidity, and the so-called intrinsic curvature [127] on membrane protein functioning is 
not well understood. The need for molecular probes is well fulfilled by small channel-forming  
peptide-based toxins, such as gramicidin A, studied in a model systems under controlled conditions. 
Originally, GrA and its derivatives were used to study membrane mechanics. Andersen and colleagues 
investigated the correlations between membrane thickness, viscosity, and bending rigidity, and channel 
lifetime. For details of these studies, we direct the reader to several reviews [48,128]. 
Apart from their well-recognized application in studying membrane mechanics, small channel-forming 
peptides have been employed as sensitive probes to monitor surface membrane properties, in particular, 
membrane electrostatics. For the most part, the phospholipid molecules, which are the building blocks 
of the cellular membranes, contain zwitterionic or negatively charged headgroups exposed on the 
membrane/water interface. Distribution of these groups affects combined operation of the  
membrane-associated molecules, because electrostatic forces are important for many interactions 
within and between macromolecules. The interaction of proteins, nucleic acids, phospholipids, and 
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their supra-molecular assemblies with the membranes affects general system electrostatics. In addition, 
the membrane surface potential is involved in regulation of membrane transport and cell/cell 
recognition [129,130]. The small channel-forming peptides can serve as the sensitive probes to monitor 
the properties of their immediate membrane surrounding. 
It was established relatively early that the conductance of GrA channels is a strong function of the 
membrane surface charge [131]. The ion conductance of the bilayer-embedded GrA pore increases 
with an increase in percentage of the negatively charged surface bilayer groups. The charges on a 
membrane surface attract counter-ions and reduce the concentration of the co-ions near the entrance 
of the pore, thus increasing or decreasing a number of the cations, depending on the sign of the 
surface charge. The effects of the surface charge in GrA conductance are especially strong at low 
electrolyte concentrations. 
Rostovtseva and colleagues analyzed the gramicidin pore conductance varying percentage of the 
charged lipids in a bilayer composition at different pH and salt concentrations [50]. Deviations of a 
single pore conductance from the predictions made using the Gouy-Chapman formalism allowed for 
estimation of the ―intrinsic‖ pK values of the charged lipids at the surface of the bilayer. Thus, the GrA 
pore conductance was used to detect minute changes in the membrane surface charge density, 
supporting the results obtained using different surface charge identifying techniques [129,132]. 
Borisenko and collaborators [49] attached protonated chemical groups on the gramicidin molecules to 
create gramicidin-ethylenediamine and gramicidin-histamine peptides (Figure 4a). 
Figure 4. (a) Model representation of the engineered GrA-ethylenediamine channel in a 
lipid bilayer [49]. At both entrances of the channels, an ionizable site (the primary amino 
group in gram-ethylenediamine; the imidazole group in gramicidin-histamine) is connected 
to the gramicidin backbone via a carbamate linkage). Representative single-channel 
currents of gramicidin-ethylenediamine (b) and gramicidin-histamine (c) at different pH 
values [49]. The closed channel states are seen as the zero current levels. The currents of 
the trans (It) and cis (Ic) isomeric states of the channel are indicated. Reprinted and 
modified with permission from reference [49]. ScienceDirect open archive. 
 
Both GrA variants were able to form single-molecule pH-sensitive pores, by displaying additional 
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modified GrA channels with lysine substitution on the C-terminal, allowing for channel activation at 
the specifically high pH were recently reported [133]. 
Sensitivity of the gramicidin channels to the membrane surface properties determined their  
use in the applications focusing on probing changes in the membrane charged state. Mayer and 
colleagues [52] used the unmodified GrA to monitor enzymatic activity of the phospholipases D and C 
(PLD and PLC). These enzymes are cleaving specific phosphodiester bonds in the phospholipid 
headgroups, resulting in accumulation of charged or non-charged lipid species. Charged state of the 
membrane surface was changed, which, in the presence of the low electrolyte solution, was expected to 
influence GrA channel conductance. Indeed, application of PLD to the uncharged phosphatidylcholine 
membranes significantly increased the unitary GrA channel conductance. This change could be related 
to a conversion of the phosphatidylcholine lipids into the negatively charged phosphatidic acid, which, 
in turn, generates an increase in cation concentration at the membrane surface and, thereby, inside the 
channel (Figure 5). 
Figure 5. Monitoring activity of phospholipase D (PLD) in the model lipid bilayers by 
changes in single channel conductance of GrA pores [52]. (a) As PLD hydrolyzes 
electrically neutral PC lipids and produces negatively charged PA lipids, the membrane 
negative charge is generated. It induces accumulation of the cations close to the membrane 
surface, leading to a significant increase in channel conductance. Negative charges are 
shown in red, and positive ions are shown in blue; (b) GrA unitary current vs. time 
recordings before and after addition of PLD. Reprinted with permission from reference [52]. 
Copyright 2009 American Chemical Society. 
 
PLC activity in the negatively charged bilayers produces a significant decrease in the GrA 
conductance, reducing membrane content of the negatively charged phosphatidylinositol. Similarly, 
picomolar additions of alkaline phosphatase were monitored by attaching an enzyme-cleavable phosphate 
group on the C-terminal end of the GrA derivative [134]. In this case, cleavage of the negatively charged 
phosphate group reduces the concentration of cations only in the direct vicinity of the channel opening.  
GrA and similar small toxins can be used to probe the electrostatic interactions of charged peptides 
and counter-ions with the membranes. For example, the membrane surface charge modification 
induced by adsorption of polyvalent cations and positively charged cargo peptides could be 
quantitatively detected [34,51]. Similarly, conductance of another small toxin, syringomycin E [135], 
was used to monitor adsorption of DNA on the positively charged bilayers [136]. 
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4.2. Molecular Sensing with αHL, PA63, and GrA 
Accurate and rapid molecular detection is vital for basic research, medicine, technology, and 
defense. Biological nanopores, including the channel-forming bacterial toxins, are natural single-molecule 
biosensors evolved to stochastically detect their substrates. In the model lipid bilayers, this detection is 
often manifested by reversible current fluctuations between open and closed states. The frequency, 
duration and magnitude of the ―on/off‖ closures are defined by the concentration, size, charge, and 
other physicochemical characteristics of the substrates and analytes. 
Over the past two decades, wild-type and genetically or chemically modified αHL was extensively 
investigated as the molecular sensor able to detect a variety of analytes. The ionic species and organic 
molecules tested include DNA and RNA biopolymers [137], proteins [138], cyclodextrins [73,139,140], 
divalent metal ions [141–143], phosphate anions [144], trinitrotoluene [145], styryl dyes [146],  
β-lactam antibiotics [147,148], heparin [149], chemical warfare agents [150], and neurotransmitters [151]. 
One of the fascinating examples of the αHL’s biosensing properties is its ability to reversibly bind 
β-cyclodextrin-based (βCD) molecular adapters. In 1999, Bayley and colleagues equipped a single 
αHL channel with an internal, non-covalently bound βCD that was able to mediate channel blocking 
by organic analytes, such as adamantanamine hydrochloride, adamantine carboxylic acid, promethazine, 
and imipramine (Figure 6) [139]. The symmetry match between the heptameric αHL channel and the 
7-fold-symmetrical ring-shaped βCD as well as a hydrophilic β-CD’s exterior and proper dimensions 
assure comfortable fit between the single βCD and the αHL channel lumen (Figure 6b). 
The blockage events were detected when the non-modified cyclodextrins were added to the trans 
but not cis side of the chamber. Note that 6-fold symmetrical αCD and 8-fold symmetrical CD were 
also able to reversibly interact with the channel [139]; αHL mutants able to bind βCD from the cis side 
were later identified [73]. Because the βCD-induced current blockage events were partial (64% of the 
total current) (Figure 6a, 2nd trace), leaving possibilities for the further current decrease, and because 
of the known ability of cyclodextrins to host different organic ―guest‖ molecules in their hydrophobic 
interior, the αHL/βCD system was suggested [139] and further investigated as a stochastic sensor for 
organic molecules. It turned out that several βCD analytes (Figure 6a, 2nd and 3rd traces) were able to 
further decrease the current through a single αHL channel, while not affecting the completely open 
channel. The recorded signals not only were used for the analyte detection but also for their 
quantification. Moreover, the authors explicitly showed that, when applied in mixtures, the αHL/βCD 
―guests‖ could be stochastically detected and quantified simultaneously by a single sensor element 
(Figure 6c) [139]. Interestingly, the wild type αHL and various mutants became more anion selective 
after the βCD binding, whereas the negatively charged adapter, hepta-6-sulfato-βCD generated 
selectivity to cations [140]. To understand how βCD affects ion selectivity, Roux and colleagues 
performed molecular dynamic simulations and potential of mean force calculations using αHL with 
and without the βCD adapter [152,153]. The authors demonstrated that the narrow βCD adapter 
increases the anion selectivity of αHL because it locally reduces the radius of the pore, which results in 
a decrease in ionic screening and dielectric shielding of the strong electrostatic field induced by a ring 
of positively charged side chains of αHL [153]. βCD also induces a partial dissolvation of ions and 
affects the orientation of nearby charged residues [152]. 
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Figure 6. (a) Bilayer recordings showing the interaction of a single αHL pore with  
β-cyclodextrin and model analytes 2-adamantanamine and 1-adamantanecarboxylic acid; 
(b) Molecular graphics representation of the interaction between αHL and cyclodextrin;  
(c) Analysis of drug molecules by stochastic sensing with αHL and a βCD or γCD adapter. 
Reprinted and modified with permission from reference [139]. Copyright 1999 Nature 
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Interaction of CD with αHL was shown to be pH and voltage dependent; the apparent βCD 
dissociation constant varied from ~3.1 × 10
−3
 to ~2.1 × 10
−2
 M in pH 5–11 range, and from  
~3.1 × 10
−3
 to ~1.4 × 10
−2
 M with voltage change from −40 mV to +40 mV [73]. Moreover, the αHL 
mutants that bind the βCD adapter ~10
4
 times more tightly than the wild type have been designed and 
investigated both with the planar lipid bilayers and high resolution x-ray crystallography [154]. 
Clearly, the mutant pores with the extended βCD dwell time can serve as improved noncovalent 
molecular adapters [155], because sensing with molecular adapters would be more effective if the 
adapter did not frequently dissociate from the channel, leaving αHL unable to detect analytes [156]. To 
increase strength of the βCD/αHL interaction, the authors covalently attached β-CD within the α-HL 
pore in two possible molecular orientations by using a specific linker [156]. A modified βCD-based  
adapter, where a single oxygen atom in its ring skeleton was replaced by a disulfide unit, was also 
investigated [157]. A heptameric αHL pore capable to accommodate two different βCD-based adapters 
at distinct binding sites was engineered [158]. Non-modified β-CD and hepta-6-sulfato-βCD were 
lodged simultaneously within the lumen of a single αHL pore that was genetically engineered to 
accommodate them. The space between the adapters was characterized as ~4400 Å
3
 ―nanocavity‖ for 
which the adapters served as gates at the cis and trans ends of the cavity [158]. The CD-based adapters 
were employed to investigate the dynamic aspects of the Hofmeister effect [159] and to discriminate 
between the S- and R-enantiomers of the ibuprofen and thalidomide drug molecules [160]. 
Cyclodextrin’s ability to enter a protein pore and reversibly occlude it was explored by a rational 
design of the channel blocking antitoxins to target both αHL [161,162] and binary bacterial anthrax, 
C2, and iota toxins [102,114,163–170] (recently reviewed in refs. [86,115,171]). Briefly, the idea was 
to directly obstruct these channels from the physiologically relevant cis-side by compounds of the 
same symmetry as the target pore [163]. According to the diffusion model of Berezhkovskii and 
Bezrukov, for the blocking molecule to be therapeutically effective the attraction between the molecule 
and the channel should be strong enough to allow the molecule to stay in the channel for sufficiently 
long, thus blocking translocation of other molecules [172,173]. The PA63 prepore internal diameter 
was estimated to be between 20 and 35 Å [106] with the PA63 pore’s constriction region not exceeding 
12 Å [113,174,175]. This finding guided the choice of the ~15-Å 7-fold symmetrical CDs as the 
potential core structures for blocker design. Because the PA63 channel, the binding component of the 
anthrax toxin is preferentially selective to cations, βCD molecules were rationally modified to 
incorporate seven positive charges (amino groups) covalently linked to the cyclodextrin’s core by 
hydrocarbon linkers of different nature and length [163]. Several 7+βCDs were custom-synthesized 
and tested in the planar bilayers, in cell assays [102,114,163,168], and in vivo [167]. When a single 
phenyl group was introduced into each of the seven hydrocarbon linkers, the βCD blocker affinity to 
the pore was enhanced more than 10 times [102,165]. It was suggested that this difference is defined 
by the additional stabilizing interactions between the introduced aromatic groups and -clamp  
(see Section 5.2). Indeed, two of the tested βCD blockers were significantly less potent with the F427A 
mutant of PA63 [102]. The authors also made a step towards understanding the physical forces 
responsible for the pore-blocker interactions by analyzing the dependence of interaction strength and 
underlying kinetics on the salt concentration and applied transmembrane potential [102]. It was shown 
that in the binding reaction of the 7+βCD to the channels, salt-concentration independent, short-range 
forces predominate. In the case of the blockers equipped with the aromatic linkers, the binding was 
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further enhanced. At moderate and low salt concentrations, the blockers’ residence times were 
influenced by long-range Coulomb interactions. The increase in the residence time as a function of 
transmembrane voltage showed the existence of an additional electrostatic component in the 
blocker/pore interactions. 
Aside from 7+βCDs, PA63 is permeable to a number of small-molecule cationic  
blockers [111,118,174–176] and some of them, especially those carrying the aromatic fragments [118] 
bind the channel at the low nM concentrations. It would be interesting, apart from the therapeutics 
applications, to explore the ability of the channel to detect positively charged analytes for the 
biosensing. In a different application, planar lipid bilayer measurements with anthrax toxin 
components were investigated as a rapid quantitative tool to recognize specific proteins and to screen 
for anthrax therapeutics [177]. The authors showed that the full-length LF and EF subunits convert the 
current/voltage relationship of the oligomeric PA63 from slightly non-linear to highly rectifying and 
diode-like. The pattern represented by the asymmetric blockage of PA63 ion channel with LF and EF 
provided the basis for the quantitative biosensor allowing one to identify and screen small molecule 
compounds and antibodies that disrupt anthrax toxin components interaction. Thus, the agents that 
bind to either PA63 (but do not block the ion current) or LF/EF would inhibit the LF/EF-induced 
rectification of the current-voltage relationship. 
Modified gramicidin was also developed as a key element of a biosensor, composed of a tethered 
bilayer on a solid support, the a system combining biological recognition mechanism with physical 
transduction [178–181]. In this application, modified GrA serves as the signal transducer: single 
molecule binding to its engineered domain modulates ability of the transmembrane pores to dimerize 
and to pass ion current. Therefore, decrease in the ion flux could be used to detect presence of the 
analytes and/or their identity. 
4.3. Sequencing of Polynucleotides with αHL 
An attractive idea to develop a relatively inexpensive and ultra-fast technique to decipher DNA and 
RNA polynucleotide sequences surfaced soon after the first reports on time-resolved polymeric 
molecules translocations across large toxin ion channels. The understanding that charged polymers can 
be successfully detected as they electrophoretically move through the appropriately narrow aperture of 
a biological nanopore under externally applied voltage had immediately provoked great interest to this 
field. The original US patent-awarded concept of the single-molecule sequencer by George Church, 
David Deamer, Daniel Branton, Richard Baldarelli, and John Kasianowicz [182] describes a 
nanoscopic channel in an artificial membrane separating two liquid-filled compartments, one of which 
contains the analyzed polymeric molecule, composed of sequential monomeric residues (Figure 7). 
The method is based on detection of changes in the ion current through a single nanopore in the 
presence of a single polymer molecule that directionally moves, one monomer at a time, through the 
pore from one electrolyte compartment to another under the influence of an externally applied electric 
field. At the same time, the different passing polymer units are expected to generate different 
displacement of the small ions from the pore, and, therefore quite distinct current blockages  
(Figure 7b). The proposed principle of ion-channel assisted sensing resembles the resistive-pulse 
Coulter counter method, which detects and counts particles passing through a capillary connecting two 
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electrolyte solutions [27]. The channel-based sequencer idea, due to its apparent simplicity and 
exciting perspectives of the fast and effective nucleic acid sequencing, has attracted multiple research 
groups to the nanopore-based sequencing field. This idea, if workable, would allow for scanning of 
polynucleotides with a µs per-base rate, making rapid sequencing of a 6 × 10
9
 base pairs of individual 
genome an achievable task. Moreover, in the originally proposed scheme, the nanopore sequencer idea did 
not require additional DNA amplification, hybridization and extensive processing, and, therefore, was 
expected to bring a tremendous improvement in clinical diagnostics and general research. 
Figure 7. (a) A scheme of single-stranded DNA characterization with an ion channel. The 
ion current through a single unoccupied pore (illustrated by the channel at the left) is 
reduced as a single-stranded DNA molecule begins its passage through the pore (illustrated 
by the channel at the right) [182]; (b) Schematic representation of DNA sequencing model 
by the ion channel method. The individual DNA bases (G, A, T, and C) interfere 
sequentially and differentially with the flow of small ions through the pore which leads to 
the discrete conductance levels characteristic of the G, A, T, and C bases. The order of 
appearance of the conductance levels sequentially corresponds to the order of bases in the 
DNA [182]; (c) Oligomers of poly[U] cause transient blockades in the single αHL channel 
current [182]. Reprinted and modified with permission from reference [182]. 
 
The early proof-of-principle experiments were performed using the wild-type αHL channel and 
RNA and single stranded DNA homopolymers, which were believed to be able to pass through the 
pore. The ion current blockades appeared immediately after polymers such as polyadenylic acid or 
polyuridylic acid were added to one side of a lipid bilayer containing a single αHL channel (Figure 7c). 
To be detected, the current-interruption events required at least 100 mV of applied voltage, positive on 
the side of the membrane opposite to the nucleic acid addition. These events were from hundreds of µs 
to several ms in duration. No channel blockage events were recorded when the polarity was reversed. 
This fact indicates that anionic nucleic acid molecules are driven through the channel 
electrophoretically [137]. As expected from the steric parameters of the αHL pore, the limiting 
aperture is 1.5 nm in diameter [78], which allows for a successful passage of only single-stranded 
DNA molecules, as shown by the quantitative PCR [137]. The additional studies produced even more 
encouraging results, showing that structurally specific homopolymers of RNA can be detected with 
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pore [183]. Thus, polyA produced blockades of ~85%, and polyC of ~95%. Dramatic differences were 
also observed in the average velocity with which the nucleotides traversed the pore at the same  
applied voltage. PolyC, for instance, passed through at 3 µs per nucleotide and polyA’s rates were  
20 µs per nucleotide. 
The concept of protein-pore based nucleotide sequencing has encountered many technical problems 
and pitfalls, even though all the steps of the original proposal, except for the reliable resolution of single 
nucleotide bases, had been successfully achieved [184–186]. To achieve a single-base resolution, ionic 
current through a pore should be affected by exactly one nucleotide at a time, while for αHL it was found 
that the pore volume can simultaneously accommodate up to 10–15 nucleotides [187,188]. Interaction of 
the electric field in the entrance of the pore with the entering nucleotide bases also affects the passing 
current [189,190]. Similarly, formation of the intra-chain intermediate structures in the passing 
nucleotide may produce blockage irregularities [184,191]. The sufficient rate of one nucleotide per 
second translocation, needed for a reliable readout, cannot be achieved at the moment, as a nucleotide 
is moving too fast under the applied electric field [137,192]. Besides, the temporal resolution of the 
pore current is highly dependent on the random motion of the polynucleotide and on non-specific 
interactions within the pore [186,188,193]; as a result, the translocation times for two identical 
molecules can differ by two orders of magnitude.  
Despite all these obstacles, great progress in this field had been achieved. The sequence of 
polynucleotides is now approached not only with the use of ionic channels of biological origin, such as 
α-hemolysin toxin and bacterial porin MspA [194], but also with engineered nanopores made in 
various synthetic materials, e.g., silicon nitride [186,195]. These studies are not reviewed here and 
their description is provided elsewhere [185,186,195,196].  
The task of individual polynucleotide bases recognition with αHL can be approached using different 
strategies. One technique focuses on slowing down the overall transport of a polynuceotide chain 
across the pore, so only one nucleotide in the chain is affecting the pore current. For instance, the DNA 
pseudorotaxane species that carry a hairpin structure at one end can be trapped in the process of 
translocation through the channel [197]. Reproducible current blockages are observed for various 
nucleotides positioned in the ―scanning‖ constriction of the αHL pore. Similarly, the polynucleotide 
immobilization in the pore has been achieved by attaching streptavidin and biotin linkers to the 
scanned molecule [198,199]. The use of immobilized DNA allowed identification of the two specific 
regions within the lumen of αHL that could distinguish individual bases in polynucleotide (Figure 8a). 
Another approach employs both rotoxan-additions into DNA chain and specific enzyme complexes 
(DNA polymerase) that slowly feed a DNA molecule into a pore in a ratchet-like motion, providing an 
improved signal-to-noise ratio [200–203]. The engineered pores of αHL modified to accommodate a 
specifically designed molecular adaptor of cyclodextrin also allowed for an improved sensitivity of this 
pore complex for passing individual nucleotides [199,204]. A combinational method was recently 
suggested [205]. In particular, the αHL pore, equipped with the permanently attached cyclodextrin 
adapter was able to electrically recognize single ribonucleoside diphosphates as they were processively 
cleaved from the analyzed polymer chain by the channel-attached enzyme, processive exoribonuclease 
(Figure 8b). 
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Figure 8. A αHL nanopore can be used to detect the single nucleotides in single-stranded 
DNA or RNA molecules. (a) A homopolymeric DNA oligonucleotide (blue circles) can be 
immobilized inside the αHL pore with a biotin (yellow)/streptavidin (red) linkage [199]; 
(b) Detection of the individual nucleotides cleaved from a single stranded RNA by 
polynucleotide phosphorylase [205]. Schematic representation of RNA oligonucleotide 
(circles) digested by polynucleotide phosphorylase (PNPase, green), one base at a time. 
The unbound nucleotides (rNDPs) are detected by the mutant M113R αHL (mutation 
highlighted in blue) pore equipped with a cyclodextrin adapter (orange). Reprinted with 
permission from references [199,205]. 
 
5. Channel-Forming Bacterial Toxins to Investigate Protein and Other Macromolecule Transport 
Macromolecule transport across bilayer membranes is one of the most fundamental and complex 
life phenomena. In a recently published book [206], Muthukumar describes the process of macromolecule 
translocation as an ubiquitous phenomenon where electrically charged polymer molecules move to and 
from a highly crowded cell environment to make as a thick ―Coulomb soup‖. Comprehensive 
understanding of principles and regularities involved in the macromolecule transport is lacking and 
often requires investigation of an isolated translocation process in vitro since many biological translocation 
processes are too phenomenologically rich and complex for a direct in vivo investigation [206].  
One of the powerful methods to probe polymer transport in vitro involves single or multi-molecule 
nanopore-based translocation experiments performed in the model bilayer lipid membranes. In a 
number of these studies, channel-forming bacterial toxins were used to exploit the pore-mediated 
uptake of natural and foreign polymer substrates. To a large degree, these studies were inspired by the 
successes in the nanopore-based nucleic acid sequencing research that we described above. However, 
protein translocation studies are believed to be somewhat more complicated [207]. In contrast to the 
linear homogeneously charged single-stranded DNA homopolymers, proteins contain multiple 
positively or negatively charged residues and polar and hydrophobic side chains and, therefore, are 
charged non-homogeneously. Besides, large polypeptides are usually folded into different structures 
and exist in a variety of transition states and conformations. Therefore, one of the most critical steps 
for the protein to navigate through the narrow biological pores would be the necessity to undergo 
substantial conformational transitions, including unfolding. Despite the complexity of the systems, 
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several groups have provided essential insight into protein translocation processes using the model 
lipid bilayer techniques. 
5.1. Studying Polymer and Protein Transport with aHL 
The main body of publications on polymer and protein translocations investigated with the 
resistive-pulse sensing approach uses single αHL channels, wild type or variants, reconstituted into the 
artificial bilayer lipid membranes. In 1992, Krasilnikov and colleagues developed an elegant approach 
to estimate the effective radius of an ion channel based on the conductivity measurements performed in 
the presence and in the absence of water-soluble polymers, polyethylene glycols (PEGs) of different 
molecular weights [208]. The method was later use to determine the geometry of different ion channels, 
including the pores of αHL [71] and PA63 [209], discussed here. The approach was further refined to 
allow not only for determining the size of channel openings but also to detect the presence, size, and 
apparent localization of structural constrictions inside the pore [71]. The method was based on the 
effect of asymmetrical addition of PEG on the channel conductance. 
An approach for covalent attachment of the single PEG molecules within the lumen of the αHL 
pore has been described [210]. When the polymer was functionalized by a covalently attached biotin 
molecule, the tethered polymer was detected on both the cis and trans sides of the membrane using 
genetically engineered streptavidin mutants with a weakened binding affinity [211]. Such a covalently 
attached and functionalized ―moving arm‖ is designed to move across the bilayer from one opening of 
the pore to another and could be used as a sensor element for detecting protein analytes. Interestingly, 
closing linear PEG molecules into a circular ―crown‖ substantially modifies their dynamics in the αHL 
pore [212]. In contrast to the linear PEGs, the blockage efficiency of the crown exhibits a strong 
dependence on both the sign and magnitude of the applied voltage (voltage asymmetry). The authors 
suggest that the charged rigid crown/K
+
 complex is responsible for the blockage. The closing of a 
linear polymer molecule into a circle changes its pore translocation because the complex of this cyclic 
molecule with a K
+
 ion faces an effective barrier in the channel. The capture and release of single PEG 
molecules by the αHL channel were detected as time-resolved reversible current-fluctuation events 
when extreme KCl concentrations (4 M) were used [213]. Remarkably, the capture on-rate, or 
fluctuation frequency, decreased monotonically with the PEG size, whereas the residence time of the 
polymer inside the channel showed a crossover behavior, initially increasing but then decreasing with 
molecular weight of the polymers. The authors suggest that the αHL channel is not spacious enough to 
accommodate larger PEG molecules and that the out-of-pore portion of the polymer molecule acts as 
an entropic spring pulling on the trapped part and thereby decreasing the residence time of the proteins 
in the channel. 
Furthermore, the αHL variants carrying different point cysteine mutations were probed with small 
water-soluble sulfhydryl-specific reagents of different charge and mass [74,214]. These polymers bind 
to the cysteine side chains exposed into the aqueous phase in the αHL lumen by forming disulfide 
linkages at different locations. This allowed one to determine the location of a constriction at the 
midpoint of the pore lumen [74]. The results also suggested that the net charge of an αHL channel 
lumen defines the weak anionic selectivity of the channel and that the charge at the pore entrances 
determines the shape of the conductance-voltage dependencies [214]. Muthukumar’s group investigated 
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the molecular mechanisms responsible for the two-level ionic current blockages produced by single 
poly(styrene sulfonate) molecules passing a single αHL pore under an electric field [215]. The authors 
showed that only the current reduction sub-events with deep current blockages were successful 
translocations. However, changing the pH on the trans-side of the pore allowed for tuning the effective 
charge of the β-barrel and for dramatic increase in frequency of the successful translocation events. 
The authors also developed a stochastic theory with a pairwise free energy profile with polymer/pore 
interaction, that was qualitatively consistent with the experimental results [215]. A capture of single 
molecules of sodium poly(styrene sulfonate) by αHL was also studied under varying transmembrane 
voltage, pH, and salt concentration asymmetry conditions [216]. The study reports that the 
electrophoretic capture of single polymer molecules by a αHL pore under salt concentration gradients 
is controlled by a combination of pore/polymer electrostatic interaction and induced drift force due to 
the salt concentration asymmetry. Besides, at higher pH, the polymer/pore interaction is repulsive and 
lowering the cis compartment salt concentration increases the effect. At lower pH, the polymer/pore 
interaction becomes attractive and the effect is stronger at lower cis compartment salt concentrations. 
The authors propose a hypothesis of an antagonistic/synergistic coupling between the pore/polymer 
interaction and induced drift by salt concentration asymmetry [216]. 
The interactions between the αHL’s β-barrel pore and positively charged signal α-helical peptides 
were also examined [138]. The transport of the specifically designed peptides with a central lysine 
residue within the repeat unit (Ac-(AAKAA)mY-NH2, m = 2–7) was investigated with a focus on the 
contribution of peptide charge and length to the free energy barrier for the translocation. The authors 
found that the kinetic parameters of the peptide/pore binding reaction were strongly dependent on 
transmembrane voltage and peptide length. In particular, a rise in event frequency with the increasing 
of the applied transmembrane voltage and a reduction in event frequency for longer peptides were 
reported. The collagen-like peptides existing as mixtures of single, double, and triple helices were also 
distinguished and identified by comparing their characteristic translocation parameters through  
αHL [217]. αHL, together with aerolysin of Aeromonas hydrophila, was used to analyze transport of 
several α-helical peptides of the sequence fluorenylmethoxycarbonyl (Fmoc)-DnAxKy [218]. A net negative 
charge of these peptides has allowed them to be driven through the pores by the applied voltage. 
Several studies were designed to use biological nanopores to probe protein folding. Thus, Auvray 
and collaborators investigated the transport of partially folded and unfolded maltose-binding proteins 
through αHL under conditions that favored protein denaturation [219]. Movileanu and collaborators 
reported related effects when polypeptides with various β-hairpin structures produced longer ion 
current blockages by comparison with no-hairpin containing peptides [220]. The unfolding of the 
protein was shown to be important in facilitating its translocation through αHL pore, and, apparently, 
is the rate-limiting step for nanopore-mediated protein translocation in many systems. More recently, a 
technique that allowed proteins to be unfolded for processive translocation was described [221]. The 
authors investigate controlled unfolding and translocation of proteins through αHL using the protein 
unfoldase ClpX, which is a component of the ClpXP proteasome-like complex responsible for the 
targeted degradation of numerous protein substrates in E. coli and other organisms. ClpX acts by 
forming a homohexameric ring that uses ATP hydrolysis to unfold and translocate proteins through its 
central pore and generates sufficient mechanical force to denature stable protein folds. To examine  
co-translational unfolding of individual protein molecules, the protein substrates were tagged with 
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oligonucleotides to enable potential-driven unidirectional movement through αHL [222]. The kinetics 
of the co-translocational unfolding of thioredoxin, which is a model protein of 108 amino acids was 
then tested at the single-molecule single αHL level. The study revealed a four-step mechanism that 
includes two separate unfolding events with a detectable, partly unfolded intermediate. A molecular 
description for each step is provided [222]. Interestingly the authors suggest that the general 
mechanism for the co-translocational protein unfolding that they describe is broadly similar the one 
proposed by Krantz and colleagues for the PA63-mediated uptake of lethal toxin of anthrax [223] 
(discussed in detail in the Section 5.2). The thioredoxin translocation through αHL was recently 
presented as proof-of-principle system for detection of protein phosphorylation [224]. 
Another important factor in protein transport is the ability of the protein to interact with the binding 
sites within the pore lumen. To understand how this interaction alters the underlying kinetics of polypeptide 
translocation, αHL variants with acidic binding sites composed of rings of negatively charged aspartic 
acid residues placed at the strategic positions within the β-barrel were engineered [225]. These 
mutations resulted in a significantly enhanced transport of cationic polypeptides across the membrane. 
For instance, when the entry and exit of the β-barrel were modified with the electrostatic binding sites, 
both the on- and off-rate of the polypeptide/channel binding reaction were significantly increased 
because of decrease in the free energy barrier for translocation. At the same time, hydrophobic 
polypeptides faced a greater energetic barrier and translocated at a considerably lower rate compared 
with the positively charged hydrophilic polypeptides [225]. To determine the sensitivity of the  
single-molecule pore recordings to the changes in biophysical features of the pore lumen or the 
interacting polypeptide, Mohammad and Movileanu used electrical recordings on a single αHL pore 
probed with short (~25 residues) cationic polypeptides and small folded pb2-Ba proteins consisted of 
positively charged precytochrome b2 fragments fused into the small (~110 residues) ribonuclease 
barnase [226]. The αHL pore contained negatively charged electrostatic traps and the kinetics of the 
polypeptide/pore interaction was shown to be dependent on the trap location. At the same time, the 
positive charge carried by the pb2-Ba proteins was not sufficient to allow the protein to undergo a 
substantial partition into the pore lumen. The authors followed these studies [225,226] with a simple 
model to describe nanopore-mediated translocation of the semi-flexible polypeptides, whose contour 
length is comparable with the length of the protein pore [227]. The impact of charge reversals of the 
αHL’s residues was also investigated with the pore variants where lysines were replaced with aspartic 
acids [228]. The study showed that charge-reversal mutations that disrupted ion-pair interactions on 
the cis opening of the β-barrel produced rather quiet electrical signals with reduced single-pore 
conductance, whereas disruption of an ion-pair interaction on the solvent-exposed trans opening of  
the β-barrel led to a significant gating activity, larger amplitude, and frequent current fluctuations in 
the pore. At the same time, the combination of the two charge-reversal mutations resulted in the 
irreversible collapse of the β-barrel detected as a large-amplitude permanent blockage of the channel 
current. The authors suggest that these distant charge reversals are energetically coupled and have 
different impacts on the ionic transport, conductance, and probability of the open state of the αHL 
channel [228]. The model allowed for calculation of the relative and absolute exit frequencies of the 
short cationic polypeptides through the cis and trans openings of the pore and for quantitative 
assessment of the polypeptide translocation kinetics. The kinetics of peptide/pore interactions was also 
investigated with peptides containing mainly aromatic amino acids in αHL pores engineered with 
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aromatic binding sites [229]. The authors reported that with an increase in the peptide length, both the 
event mean dwell time and the amplitude of current blockage increases whereas the events frequency 
shows only slow increase, indicating that the binding affinities of the peptides are mainly dependent on the 
off-rate constants rather than on the on-rate constants. Besides, with more aromatic binding sites 
engineered in the pore lumen, a stronger binding affinity between peptides and the pore was detected [229]. 
Nanopore analysis was also suggested for studying the misfolding of certain proteins, for instance 
amyloids, α-synucleins and prions [230,231]. The αHL pores were used to probe the different 
aggregation transition of β-Amyloid 42 (A42) (Figure 9a) [231]. 
Figure 9. Detecting intrinsically disordered amyloid peptides, Ab42 [231] and  
α-synuclein [232] with αHL nanopore. (a) Aβ42 in the presence and absence of  
β-cyclodextrin (Aβ42-CD) or Congo Red (Aβ42-CR) added from the cis-side chamber 
(top). Representation of the blockage behavior of the translocation event of Aβ42-CR 
(bottom); ―i‖ is equal to the difference between the open pore current and the average 
amplitude of the blockage current, ―t‖ is the duration time of the blockage [231];  
(b) Schematic model of α-synuclein interaction with the αHL channel pore [232]. While 
the membrane-bound helical part of α-synuclein stays on one side of the membrane, the 
highly negatively charged C-terminal tail of the protein (red/solid line) enters the αHL pore 
from the trans-side and goes past the channel constriction under the externally applied 
electric field. Reprinted with permission from references [231,232]. 
 
Aβ42 is the predominant form of the amyloid peptide, which is found in the plaques of the brains of 
Alzheimer’s patients and is an abundant component in amyloid aggregates. The peptide was studied in 
the presence of β-cyclodextrin, which promotes Aβ42 aggregation, and in the presence of Congo red, 
which inhibits the aggregation. These induced differences in the Aβ42 aggregation states were 
analyzed by monitoring the corresponding characteristic blockage events where β-cyclodextrin and 
Congo red were used to promote or inhibit Aβ42 aggregation, respectively. More recently, αHL was 
utilized to investigate the elongation of wild type α-synuclein and A53T α-synuclein monomers [230,233]. 
α-synuclein is a neuronal water-soluble protein involved in the etiology of Parkinson disease and other 
neurodegenerative dementias through formation of the α-synuclein fibrils. Gurnev et al., observed 95% 
blockage of the current by α-synuclein when the compound was added from the membrane side where 
the shorter stem part of the channel was exposed [232] (Figure 9b). The applied potential was more 
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negative on the side of α-synuclein addition. The binding reaction on-rate was reported to depend 
strongly on the membrane lipid composition. In particular, in diphytanoylphosphocholine membranes 
α-synuclein binding was about two orders of magnitude stronger compared with membranes made 
with dioleyl lipids. The turnover dependence of the dwell time on the applied transmembrane voltage 
strongly suggested the α-synuclein translocation. Besides, when the unstructured C-terminal domain of 
α-synuclein had the last 25 amino-acid residues, including nine carboxylates, removed, the compound’s 
binding affinity dramatically decreased. At the same time, measurements of the binding/translocation 
reaction parameters in 4 M KCl solutions showed impressive increase in the pore-protein attraction, 
possibly reflecting the osmotic and crowding effects in α-synuclein/pore interaction.  
Investigation of αHL pores for the stochastic sensing applications often involves substantial 
reengineering of the wild type channel. Thus, a new type of stochastic sensor based on a αHL pore 
modified with an aptamer was recently reported [234]. The aptamer was bound to the channel by 
hybridization to an oligonucleotide that is attached covalently to a single cysteine residue through a 
disulfide bond near an entrance of the pore. In this way, the oligonucleotide acts as an adapter to which 
various nucleic acid ligands can be coupled by duplex formation. The authors demonstrate that thrombin 
was interacting with a 15-mer DNA aptamer at nM concentrations forming a cation-stabilized quadruplex.  
5.2. Studying Protein Transport with PA63 
The substantial progress in understanding the physical principles governing anthrax toxin uptake is 
due to the pioneering lipid bilayer measurements performed by Finkelstein and Collier’s groups and, 
more recently, by Krantz’s group (reviewed in refs. [100,235,236]). The very first study investigating 
protein transport using the anthrax toxin was designed to answer the following two questions: (1) can 
LF and EF be translocated across a planar bilayer membranes in the absence of any cellular 
components; and (2) does the PA63 channel act as a conduit for this process [117]? Earlier studies with 
single-chain diphtheria (DT) and botulinum toxins (BT) showed that the A portion of the protein can 
be transported across a planar lipid membrane without the aid of any cellular components and, 
therefore, all of the translocation machinery for DT and BT is built into their B fragments [237,238]. 
At the same time, binary anthrax toxin has a significant advantage over the single-chain AB-type DT 
and BT toxins [117]. In particular, the channel incorporation and protein translocation events are 
separated in binary toxins, meaning that in the model studies of multiple or single PA63 channels could 
be reconstituted first and LF and EF added later. The authors believe that, if under these conditions 
translocation is captured, then the channel is not just a ―discarded wrapper‖ [117]. An electrophysiological 
system for studying translocation across planar bilayer membrane is shown in Figure 10. 
In contrast to the majority of publications where protein translocation through αHL was investigated, 
the authors chose to focus on the multi PA63 channel membranes. In a typical experiment, the pre-
activated PA63 was added to the cis compartments of the bilayer chamber at 20 mV cis side positive 
transmembrane voltage until channel formation reached steady state, which was indicated by 
stabilization of the ion current [117,239]. The substrates (LFN, LF, EF or their variants) were then 
added to the cis compartment at the concentration that allows blockage of 95% of current. The unbound 
substrate was removed by perfusion from the cis compartment solution. The protein translocation 
leading to channel lumen unblocking was recorded as the increase in conductance vs. time.  
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This process was triggered by either increase in the applied voltage to D  40 mV (Figure 10b) or by 
creating pH gradient, pHtrans > pHcis (Figure 10c) [117,239,240]. At the same time, the DpH that the 
authors used to mimic a proton gradient across an endosomal membrane was more efficient in 
stimulating protein transport, allowing translocation not only LFN but also full-length LF and EF. The 
conductance rise was S-shaped, and its rate increased systematically both with increasing of D and 
DpH. With the minimum PA63-binding translocation component domain of LF, LFN, it was shown that, 
under small D, the N terminus of bound LFN enters the oligomeric channel and initiates the threading 
of the substrate across the bilayer membrane [116]. 
Figure 10. The interaction of LFN with the PA63 multichannel membrane [239]. (a) After 
the macroscopic PA63-induced current had reached a steady state at +20 mV, ~3 nM LFN 
was added to the cis compartment of the chamber, which resulted in a rapid fall in current. 
The cis compartment was then perfused of unbound LFN. At time zero, the voltage was 
increased to +50 mV, and LFN translocation kinetics through the PA63 channels was 
indicated by the increase in conductance vs. time; (b) Kinetic transients for LFN 
translocation at +60 mV and the indicated symmetrical pH values; (c) The rate of LFN 
translocation is controlled by the magnitude and sign of the transmembrane DpH  
(pHtrans > pHcis); (d) A schematic illustration of the tandem Brownian ratchet translocation 
mechanism shows a model of several partially unfolded intermediates of LFN during 
translocation [239]. The scheme demonstrates how the hydrophobic, ϕ-clamp ratchet and 
the protonation-state ratchet may work together facilitating translocation of LFN. Reprinted 
with permission from reference [239].  
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In order to identify residues in the PA63 lumen important for the channel-mediated transport of a 
substrate, the authors used cysteine-scanning mutagenesis coupled to [2-(trimethylammonium ethyl] 
methanethiosulfonate (MTS-ET) modifications [241]. The channels were the most significantly 
affected by Phe427/Cys427 modifications, and Phe427 (named -clamp is the most hydrophobic 
residue in the otherwise hydrophilic pore lining [118]. In particular, when the bulky 427 phenylalanine 
residue was replaced by the small alanine, the single-channel conductance expectably increased but the 
rate of LFN translocation reduced by a factor of six [239]. Based on the fact that the -clamp mutation 
blocked LF translocation in cell assays [242] or significantly slowed it in vitro [118], a chaperone 
model was suggested in which the -clamp’s phenyl rings directly interacted with the translocating 
polypeptide. According to the model [118], the -clamp recognizes substrates through the hydrophobic 
effects, enhanced by aromatic-aromatic, -, and cation- interactions, and stabilizes the fragments it 
an unfolded state. This study for the first time provided evidence that PA63 was not a passive tunnel 
through which proteins electrophorese but rather an active player in facilitating the transport of a 
substrate molecule. At the same time, the lumen of a 14-strand β-barrel PA63 is believed to be as 
narrow as 12–15 Å [101,174,243], which would allow the pore to accommodate secondary structure 
only as large as an α-helix [244]. Therefore, translocation through PA63 would require the enzymatic 
substrates to unfold. If so, what are the factors that cause the folded LF and EF with tertiary structures to 
unfold? The authors show that one critical factor is low endosomal pH. Thus, the acidic conditions in the 
endosome are sufficient to destabilize the native structure of LFN and EFN proteins [244]. In vitro 
experiments have also revealed that the translocation process is driven by cis positive voltages [117] and 
that the PA63 channel is selective to cations [175]. Paradoxically, LFN bears a net negative charge (about 
six negative charges) even at pH values as low as 5.5 [240]. To explain this finding, the authors 
developed a model describing PA63 channel as a protein translocase rather than an unselective long 
tunnel. The easiest way for the substrates to achieve a net positive charge, which is thermodynamically 
and electrostatically required for the translocation, would be to get their aspartic and glutamic residues 
neutralized, for instance protonated [239]. Under DpH, the substrate molecule would get protons from 
the cis compartment solution (or an endosome) and discharge them into the trans compartment solution 
(or cytosol) following translocation. At the same time, the portion of LF/EF located inside the pore 
lumen would carry a net positive charge and PA63 would work as a proton-protein symporter [119].  
To address the fundamental question of the translocation driving force, the authors developed a 
novel charge state-dependent Brownian-ratchet model for the DpH-driven translocation, which is based 
on the chemical asymmetry created by DpH [239]. The probability of an aspartate or glutamate being 
in the protonated form is greater in the more acidic cis side compared to the more basic trans side, and, 
therefore, the rate of their entry is higher from the cis side than that from the trans side [240]. After the 
protonated aspartate and glutamate groups reach the cytosolic part of the membrane, they deprotonate, 
becoming negatively charged again, resulting in the electrostatic repulsion of the negatively charged 
chain fragment from the channel lined with the negatively charged residues. This electrostatic 
repulsion drives the translocation per se and enforces its directionality [100,239]. Therefore, the 
random Brownian motion of the substrate inside PA63 is biased toward the more basic trans 
compartment. Based on the experimental evidence, the authors suggest that the PA63 symporter 
achieves protein translocation using a tandem of two synergistic Brownian ratchets: the -clamp 
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ratchet, promoting the substrate unfolding, and the charge-state ratchet, which biases the entry rates of 
the substrates into the pore (Figure 10d). 
Remarkably, further experiments with planar lipid bilayers have imparted support to this model 
using essentially non-titratable negatively charged SO3
−
 groups introduced at most positions in  
LFN [119]. The voltage-driven translocation of the resulting LFN variants was dramatically reduced 
and the -clamp was determined as a significant factor in the exclusion of SO3
−
 from the channel. In 
another study, semisynthetic variants of LFN (12-263) in which selected acidic residues were replaced 
with the unnatural amino acid, cysteic acid, were examined [245]. The cysteic acid has a negatively 
charged side chain protonated only at pH values below the physiological range. Depending on the 
number of acidic residues replaced, transport of these mutants was either significantly suppressed or 
completely inhibited, whereas their binding and channel-blocking properties were comparable with 
those of wild type LFN. To determine if the substrate’s secondary structure is preserved during the 
pore-facilitated translocation, a method of trapping the polypeptide chain of the translocating protein 
within a pore was developed [121]. In order to determine the minimum number of residues that could 
traverse the PA63 oligomeric pore, the authors attached biotin to the N terminus of LFN and used 
molecular stoppers at the different positions. The trans-side streptavidin addition was used to determine 
whether the N terminus has reached the trans compartment solution. If the N terminus-stopper distance 
was long enough to allow for LFN to appear from the pore, streptavidin was able to bind the biotin. 
Otherwise, no biotin binding was recorded. The authors showed that an LFN polypeptide chain adopts 
a fully extended conformation, because it is being translocated through the channel’s stem. 
A typical characteristic of LFN translocation is its non-exponential S-shaped kinetics. At the same 
time, in most of the experiments the substrate translocation was investigated under conditions where 
two or three LFN molecules were bound to PA63 channels. To understand whether the S-shaped 
kinetics is an intrinsic characteristic of translocation kinetics or a consequence of the translocation in a 
tandem of two or three LFN molecules, a kinetic analysis of protein transport via the macroscopic and 
single-channel PA63 channels was performed [120]. The study showed that even with one LFN bound 
to PA63, the translocation kinetics is S-shaped, being, however, slower, with more than one LFN bound. 
The authors also propose a simple drift-diffusion model of LFN transport, where LFN is represented as 
a charged rod that moves subject to both Brownian motion and an applied electric field across  
the membrane [120]. 
A dramatically different model of anthrax toxin transmembrane uptake was recently suggested by 
Kasianowicz and colleagues [18]. The new model suggests that instead of LF and EF being threaded 
through the pore, anthrax toxin complexes (i.e., LF or EF bound to the PA63 channel) rupture 
membranes (Figure 11). 
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Figure 11. (a) A schematic illustration of two proposed mechanisms for PA63  
channel-mediated lethal factor (LF) and edema factor (EF) transport into the cytoplasm. 
The channel-mediated translocation model suggests that LF and EF pass through the  
pore [118,239]. The recent membrane rupturing model suggests that the enzymatically 
active anthrax toxin complexes (namely, LF or EF bound to the PA63 channel) rupture 
membranes [18]. Time course of the PA63 channel conductance with (b) LF removed 
before or (c) maintained at 1 nM during cis-side acidification. (Top rows) ~60 PA63 
channels were reconstituted into a planar bilayer membrane at pHcis|trans 7.2|7.2 (black) 
and, 1 nM LF was added to the cis chamber (blue). (Middle rows) The pHcis|trans 5.5|7.2 
gradient was formed by perfusing the cis chamber with pH 5.5 buffer that contained either 
[LF] = 0 (red) or [LF] = 1 nM (green). (Bottom rows) The neutral pH condition 
(pHcis|trans 7.2|7.2) (black) was restored by perfusing the cis chamber with pH 7.2 buffer. 
If LF was present, the cis chamber was first perfused with pH 5.5 buffer (red) then pH 7.2 
buffer (black). Reprinted with permission from reference [18].  
 
Kasianowicz et al., question the translocation model, noting that the in vitro pH gradient formation 
used in the previous translocation studies is precisely opposite to what occurs in vivo [18]. The 
translocation, manifested by PA63 ion current recovery (Figure 10), was observed either in static low 
pH conditions on both sites of the membrane (mostly with LFN) or starting with the symmetrical acid 
conditions and forming a pH gradient by raising the trans solution pH (both with LFN, EFN, LF, and EF). 
In the real in vivo systems, PA63 oligomeric prepore complexes would first bind the LF and/or EF 
subunits on the cell surface, then undergo endocytosis, and, after that, under pHendosome < pHcytosol 
conditions, the prepore/pore transition would occur. To support the alternative anthrax toxin uptake 
model, the authors show that anthrax toxin complexes can rupture both the planar bilayer and the 
droplet membranes [18]. Moreover, the transmembrane pH gradients alter the ion conducting 
properties of the PA63 pores and LF/PA63 interaction. In particular, under conditions that mimic those 
across the endosomal membrane, the strength of LF/PA63 interaction in the absence of LF excess in the 
solution is relatively weak. However the LF binding is irreversible when LF is present in bulk during 
acidification [18]. To understand the binding of LF/EF to the channel, the authors designed an 
experiment starting from essentially different experimental conditions (Figure 11b) compared with 



































Toxins 2014, 6 2509 
 
 
membranes under symmetrical pHcis = pHtrans = 7.2 conditions (Figure 11b, top). Following channel 
formation, LF was added to the cis compartment solution and the remaining unbound LF was flushed 
from the chamber. Lowering the pH cis solution to 5.5 led to a slow current increase (Figure 11b, 
middle) explained by dissociation of LF from the channel; the current continued to increase when pH 
was increased to 7.2 (Figure 11b, bottom). About 90% of current recovery was observed after  
30 min [18]. To show that acidification promotes the LF dissociation from the channel, the authors 
repeated the experiment (Figure 11c) maintaining the bulk cis-solution LF concentration at constant 
during the acidification. For that purpose, the cis solution was perfused with the LF containing pH 5.5 
buffer (Figure 11c, middle). After that, the solution was additionally perfused with LF-less pH 5.5 
buffer (Figure 11c, middle). The described procedure led to only minor increase in the current even 
after pH was return to 7.2 (Figure 11c, bottom). Thus, about 90 min after returning to initial  
pHcis = pHtrans = 7.2 conditions, only 17% of the initial PA63 current was recorded, indicating strong, 
nearly irreversible LF/PA63 interaction when [LF]bulk = 1 nM during acidification. The authors also 
showed that when LF or EF were in the bulk during acidification of the cis side, the formation of the 
essentially irreversibly bound LF:PA63 and EF:PA63 complexes led to membrane rupture.  
In addition, the article contains interesting suggestions about a possible alternative mechanism of 
the anthrax toxin uptake, which the authors support with carefully designed experiments and detailed 
discussion [18]. We believe these data must be addressed in the future. On the other hand, it is 
important to emphasize that the earlier studies showed nearly ideal positive correlation between the 
translocation rate measured for different LF, EF, and PA63 variants in vitro and cytotoxicity of the 
complexes in cell assays and in vivo. Moreover, a variety of available and rationally designed small 
molecule and polyvalent compounds aimed to specifically obstruct the PA63’s translocation pathway 
were shown to be very effective in inhibiting anthrax toxin [111,118,163,165,167,176,246]. The 
positive correlation between binding activity of these blockers to the PA63 channel in vitro and 
their protective action in vivo was reported. The dominant-negative PA mutants that co-assemble 
with the wild-type PA63 and block its ability to translocate the LF and EF components have been 
also described [247–250].  
6. Channel-Forming Bacterial Toxins for Cancer Therapy 
Many traditional anticancer agents, while being highly effective, also show their well-known toxic 
properties toward normal fast proliferating cells. These drugs were often discovered in cellular screens 
of extracts from natural sources, or in in vivo screens using a leukemic P388 mouse model, and entered 
the clinical studies and market before the exact mechanism of their action was understood [251]. In 
contrast, emergent next-generation strategies of the anticancer drug discovery focus on targeted 
therapies, where the agents are designed rationally to target the unique features of malignant cells. 
Thus, cancer cells overexpress specific tumor antigens, carbohydrate structures, and growth factor 
receptors on their surface or they express cancer specific proteases [252]. Targeting these factors is a 
widespread strategy under development for a selective killing of cancer cell using small molecules, 
monoclonal antibodies, modified bacterial, plant and fungal toxins, viral nanoparticles, and any other 
inhibitors, which follow the principles required to selectively destroy cancer cells. 
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The bacterial toxins are naturally cytotoxic: a property that makes them attractive to use in the 
targeted therapies. Thus, only one molecule of diphtheria toxin fragment A introduced into a cell can 
kill the cell [253]. The major task is to direct the cell-binding properties of the bacterial toxins for 
selective action on cancer cells while minimizing their ability to destroy healthy cells. At first, the 
targeted toxin research focused on design of so-called ―immunotoxins‖, molecules consisting of a 
protein toxin fused to a tumor cell-specific antibody or antibody fragments. This approach afterwards 
expanded to include other target-specific ligands, such as growth factors or cytokines. These proteins 
are often referred to as ―targeted toxins‖ (TTs). Pseudomonas exotoxin A of Pseudomonas aeruginosa 
and diphtheria toxin of Corynebacterium diphtheria, which enzymatically inhibit protein synthesis, are 
commonly used for the immunotoxin construction. The Clostridium and Bacillus binary toxins are also 
considered excellent candidates for the targeted toxin design. Being composed of two (or three in  
the case of anthrax toxin) nontoxic proteins, the binary toxins offer a significant advantage over the  
single-chain AB-type toxins, because activities of their binding and enzymatic components can be 
redirected independently towards targeted cancer cells. The membrane-perforating bacterial toxins and 
pore-forming antimicrobial peptides have also served as excellent tools for the targeted toxin 
research. For the specific aim of the current review, here we highlight examples of the therapeutic 
strategies that are focused on a targeted modification of the membrane-perforating bacterial toxins, 
such as αHL, and on the channel-forming components of the binary toxins, such as PA63. For 
examples of other targeted toxin applications and for a general overview of the field, we direct the 
reader to a series of recent reviews [254–264]. 
Anthrax toxin is an excellent choice for targeted toxin research [265]. The Bacillus anthracis 
infections are rare and currently only a limited number of people have been immunized against anthrax. 
According to the CDC, only laboratory workers who work with anthrax, some veterinarians,  
and some members of the US army are routinely vaccinated. Therefore, in contrast to diphtheria  
toxin (childhood immunization) and Pseudomonas exotoxin (earlier infections), most people lack  
pre-existing immunity for anthrax. Besides, the tripartite nature of the anthrax toxin offers a variety of 
tuning strategies for targeted modifications of the non-linked toxin components. Moreover, substantial 
recent progress made in the understanding of anthrax toxin protein structures and uptake mechanisms 
facilitates design of tailored antitumor agents. 
Targeted anthrax toxin research progresses in at least three different directions, which are often 
combined. First, because PA binding to the CMG2 and TEM8 cell surface receptors is the first event in 
the multistep anthrax toxin’s intracellular transit, redirecting the protein towards alternate tumor cell 
specific receptors was investigated. To demonstrate the feasibility of this approach, it was shown that 
tailor-made PA can be targeted towards the human p62 (c-Myc)-specific hybridoma cell line  
9E10 [266,267]. The C-terminus of wild-type PA was fused to the amino acid residues 410–419 of the 
human p62
c−Myc
 epitope via a (G2S)2 linker; ac-Myc IgG was proven to act as alternate receptor.  
The PA-c-Myc fusion protein was shown to kill RAW cells, which do not express the c-Myc receptor. 
The addition of the c-Myc epitope to the C-terminus of PA did not interfere with the ability of the 
fusion protein to bind to the PA TEM8 receptor. Therefore, the presence of competitive inhibitor PA 
SNKEDFF (a non-toxic receptor-binding mutant) and the fusion protein FP59 (amino acid residues 1–254 
of LF and the ADP-ribosylation domain of Pseudomonas exotoxin) was required to fully protect 9E10 
cells from a challenge with PA-c-Myc and FP59. Another receptor-redirected approach is to disrupt the 
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native receptor-binding function of the toxin and then to specifically link the mutated protein to a 
heterologous receptor-binding protein. Recently, the native receptor-binding activity of PA was ablated 
by introducing N682A and D683A mutations in domain 4 [268]. The resulting C terminus of the 
mutated protein was then fused to one of two heterologous receptor-binding proteins: human epidermal 
growth factor or the receptor-binding domain of diphtheria toxin (Figure 12). The resulting PA variants 
mediated the cell entry of the active components of the toxin. The developed approach was used to 
redirect toxin action to cells bearing the HER2 receptor [269,270]. 
Figure 12. The receptor-based approach to re-engineer PA by disrupting the native 
receptor-binding function of the toxin and specific linking of the mutated protein to a 
heterologous receptor-binding protein [268]. Composite representation of the heptameric 
prepore formed by PA63 (PDB: 1TZO) with EGF (PDB: 1JL9) linked to the C-terminus. 
An axial view of the heptameric prepore is shown, with domains 1, 2, 3, and 4 in a single 
subunit of PA63 colored magenta, green, gold, and purple, respectively. EGF is in red. 
Broken lines represent an 8-amino-acid linker (SPGHKTQP) connecting the N terminus of 
EGF to the C terminus of PA63. Reprinted with permission from reference [268]. 
 
The unique requirement that certain toxins have to be active on the cell surface of the targeted cell 
provides strategies to tailor these toxins to make them dependent on the cancer cell-specific proteases. 
Therefore, a second approach to re-engineered PA is to replace the furin cleavage site with cleavage 
sites for proteases that are present on the surface of cancer cells. For the broad-spectrum TTs, it is 
practical to focus on the cell surface-associated proteases that are overexpressed in a variety of  
tumor tissues and tumor cell lines, namely on the matrix metalloproteases (MMPs) and urokinase 
plasminogen activator (uPA, not to be confused with PA, the binding/translocation subunit of anthrax 
toxin). To examine the role of MMPs in the design of TTs, two mutated PA proteins were constructed 
in which the furin protease recognition site RKKR was replaced by the GPLGMLSQ (PA-L1) and 
GPLGLWAQ (PA-L2) sequences [271]. These fusion proteins were designed to be susceptible to 
cleavage by MMP-2, MMP-9 and MT1-MMP and were rapidly and selectively activated on the surface 
of MMP-overexpressing cancel cells. The resulting PA-L1 and PA-L2 oligomers were used to 
internalize a recombinant FP59 fusion protein and these combinations were shown to be selectively 
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toxic to MMP-overexpressing tumor cells, which included human fibrosarcoma, breast cancer, 
melanoma and thyroid carcinoma [267,271–275]. To examine the role of uPA in the design of TTs, a 
set of mutated PA proteins in which the furin activation site was replaced by uPA recognition 
sequences was also constructed [276]. The uPA substrate sequences, GSGRSA and GSGKSA were 
used to replace the furin RKKR sequence in PA, which yielded mutated PA proteins, PA-U2 and  
PA-U3 that were efficiently activated by uPA. PA-U2/FP59 was later investigated as a wide-range, 
highly selective, and highly potent chimeric toxin that specifically targets uPA-expressing tumors, 
independently of their tissue origin [277–280]. In an elegant study, Leppla and colleagues reengineered 
PA-constructing mutants with mutations affecting different LF-binding subsites and containing either 
uPA or MMP cleavage sites [281] (Figure 13a). 
Figure 13. (a) Scheme for reengineering anthrax toxin protective antigen (PA) to modify 
its action towards two distinct proteolytic activities overexpressed by the cancer  
cells [281]; (b) Scheme for discovery of PA mutants that exclusively form octamers [282]; 
(c) EM images of heptameric and octameric PA species [282]. Reprinted with permission 
from references [281,282]. 
 
These proteins contained additional mutations so that PA-U2 and PA-L1 monomeric subunits had 
to be adjacent in an oligomer to form native LF binding sites. As a result, individually the constructed 
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together to uPA and MMP overexpressing cancer cells formed functional LF-binding heteroheptamers. 
The mixture of these two mutants was highly effective in vivo to treat diverse aggressive transplanted 
tumors. In this study, the authors established proof-of-principle that anthrax toxin can be re-engineered 
in a way so that its cytotoxicity relies on two distinct proteolytic activities overexpressed by the cancer 
cell [281]. This strategy was further examined in a study where the therapeutic window of the anthrax 
toxin-based TTs was enlarged with PA variants rationally designed to selectively and exclusively form 
oligomers [282] (Figure 13b). 
The idea of this design was based on a finding made by Krantz and colleagues that PA, which for a 
long time was believed to form heptameric complexes, is also able to form octamers, and they are 
functional [107]. Moreover, conditions under which octameric oligomerization predominates were 
determined and heptamer/octamer structural comparison showed that there are two orientations of the 
receptor-binding PA domain 4, which alternate in the octamer. The molecular determinants that 
influence the stoichiometry of PA complexes were identified, e.g., the relative proportion of PA 
heptamers and octamers could be controlled by tethering domain 4 to domain 2 with two different 
length cross-links [283]. By screening a highly directed library of PA mutants, Leppla and colleagues 
identified variants that complemented each other to form octamers exclusively [282]. The authors 
started with the PA mutant D512K, which is incapable of forming oligomers (Figure 13b, top), and 
prepared a <50,000-members library of PA variants that have the D512K substitution together with 
random mutations in several residues on the complementary face of PA63 within the oligomers  
(Figure 13b, middle). The library was screened for regaining of oligomer-forming ability and then, 
after the sought variants were identified, D512K and new complementary mutations were placed into 
two separate PA proteins. As a result, the authors achieved formation of oligomers through the use of 
the two unique interfaces (wild type and mutated), which resulted in formation of even-numbered 
oligomers (Figure 13b, bottom), predominately octamers (Figure 13c). In particular, the authors 
focused on the transformants containing substitutions at residues 245 and 252. By combining  
PA-D512K with either PA K245G/R252N (abbreviated as PA-GN) or PA K245N/R252S (abbreviated 
as PA-NS) generated high toxicity comparable to that of wild type PA both in vitro and in vivo. 
However these variant were non-toxic when used individually [282].  
The third strategy is based on the fact that the PA63-mediated protein uptake machinery is effective 
enough to deliver multiple engineered variants of the native anthrax toxin LF and EF components. To 
increase the therapeutic benefit of the TTs, the native LF and EF were replaced with a variety of fusion 
proteins containing the PA63 binding N-terminal domain of LF (LFN) or EF (EFN) and different 
toxophores (the so called ―cut and paste‖ approach [265]). The resulting chimeric variants included 
LFN fused to Pseudomonas exotoxin A enzymatic domain [284], Shiga toxin enzymatic domain, 
diphtheria toxin A chain [285,286], tetanus toxin light chain [287], Clostridia difficile B toxin 
glycosylating domain [288], Haemophilus ducreyi cytolethal distending toxin B subunit [289], Bcl-XL 
protein [290], ricin toxin A chain [269], flagellin [291], and beta-lactamase [292,293]. Many of these 
heterologous proteins have been successfully delivered by PA63 (native or mutated) into the cytosol. 
However, some proteins, apparently those that were not able to adopt a partially or fully unfolded state 
at the acidic endosomal pH, have failed [267,294]. Another factor that can limit the potency of TTs is 
the stability of the enzymatic domains in the cytosol [295]. Recently, this issue has been examined 
with LFN-PEIII variants constructed with insertion of a ubiquitin domain (wild type and mutated) 
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between the targeting domain (LFN) and the catalytic ―payload‖ (PEIII) [295]. The variants were 
designed to address the previously described bias against the presence of lysine residues in enzymatic 
domains of several AB-type bacterial toxins [296]. Thus, the catalytic domains of cholera toxin, E. coli 
heat-labile toxin, Shiga-like toxin, and ricin have strong bias towards Arg relative to Lys. This 
characteristic is believed to limit the attachment of ubiquitin followed by the proteasomal degradation 
of the toxins [295,297]. Ubiquitin is a small eukaryotic regulatory protein, which, among its multiple 
functions, also has a signaling role in protein degradation. The cytosolic stability of LF and LFN-based 
chimeric proteins was shown to follow the so-called N-end rule [294,298] described by Alexander 
Varshavsky in 1986 [299]. In accordance with the N-end rule, the specific destabilizing N-terminal 
amino acid of a protein controls the effectiveness with which side chain lysine residues are 
ubiquitinated for the following proteasomal degradation. Ubiquitin, after binding to a target protein, 
can be in its turn ubiquitinated, forming polyubiquitin chains on any of the seven lysine residues within 
ubiquitin. This process is controlled by deubiquitinating (DUBs) enzymes that allow for ubiquitin to be 
released from the protein. Interestingly, LFN-Ub-PEIII fusion proteins, in which all seven lysines of the 
wild type ubiquitin were retained while the site cleaved by cytosolic DUBs was removed, were 
nontoxic, which the authors explain by a rapid ubiquitination and proteasomal degradation [295]. The 
authors also showed that the fusion protein, in which all seven lysines were substituted by arginine 
(UbKnull), had high potency exceeding that of FP59. In general, the potency of these proteins was 
highly dependent on the number of lysines retained in the ubiquitin domain and on retention of the  
C-terminal ubiquitin sequences cleaved by DUBs [295]. The stability of LFN-PEIII fusion proteins was 
also significantly improved in a study where N-terminal amino acids of LFN were mutated and all the 
lysines reductively dimethylated [300].  
Besides the single chain and binary toxins, membrane-perforating bacterial toxins were also 
considered as potential candidates for the tailored modifications. Among the bacterial pore-forming 
toxins which were investigated for their cytolytic or cytocidal properties against tumorous cells were 
α-hemolysin of Staphylococcus aureus [26,301–303], parasporin-4 of Bacillus thuringiensis [304–307], 
listeriolysin O of Listeria monocytogenes [308], aerolysin of Aeromonas hydrophila [309,310], the S 
component of Panton-Valentine lekocidin (LukS-PV) of Staphylococcus aureus [311] and epsilon 
toxin of Clostridium perfringens [312]. In particular, Bayley and colleagues explored αHL mutants in 
which channel-forming activity can be triggered or switched on and off by biochemical, chemical, or 
physical stimuli [26,301,302]. The approach was based on earlier studies, which showed that the 
subunits of a functional αHL with nicks near the midpoint of a central glycine-rich loop are supported 
by domain-domain interactions, whereas αHL oligomers containing two truncated subunits that 
overlap in the central loop had greatly reduced channel-forming activity [313–315]. Based on these 
data, the group designed overlap αHL mutants that were activated when redundant amino acids in the 
loop were removed by proteases that inactivate the wild-type protein [301]. The authors proposed that 
this strategy could be used to construct proimmunolysins, variants of αHL that would be preferentially 
activated by the cancer cell surface proteases [301]. αHL would then perforate and kill the tumor cell 
or permeabilize the cell membrane for the cytotoxic drugs that have no or low permeability [303]. 
Thus, combinatorial mutagenesis was used to obtain αHL mutants that were rapidly and preferentially 
activated by cathepsin B [303]. Cathepsin B, normally an enzymatic protein, is involved in various 
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pathologies and oncogenic processes in humans; its overexpression is correlated with invasive and 
metastatic phenotypes in cancer [316]. 
A series of tailor-made pore-forming bacterial toxins were generated for intracellular delivery of 
different types of macromolecules [317,318]. One of the main challenges drug designers face is poor 
bioavailability of the compounds as a result of poor membrane permeability. Loaded pH-sensitive 
listeriolysin O-containing liposomes were developed [319–325] and tested both in vitro and in vivo 
(see refs. [19,317] for details). Targeted drug delivery to generate protective antiviral immunity was 
also examined using the anthrax toxin [266,326–328]. Interestingly, gramicidin, the first marketed 
natural antimicrobial agent (1939) [329], was also studied for inhibition of human immunodeficiency 
virus (HIV) infection [330–333]. 
7. Concluding Remarks 
Promising new developments in nanopore biotechnology continually emerge [334]. Because of the 
overwhelming number of the reports in this popular field, the current review is not exhaustive. In this 
article, written for a special volume on ―Intracellular Traffic and Transport of Bacterial Protein 
Toxins‖, we highlight many interesting applications of channel-forming bacterial toxins in small and 
macromolecule sensing and polymer transport. For clarity, instead of discussing all pore types 
previously investigated, we focus on three structurally and functionally different bacterial toxins:  
(1) peptide gramicidin A (GrA) of Bacillus brevis, which induces lesions in cell membranes forming 
small exclusively cation-permeable channels; (2) α-hemolysin (αHL) of Staphylococcus aureus, which 
targets the host cell membranes by forming large β-barrel pores; and (3) protective antigen (PA63), the 
pore-forming B component of the anthrax toxin, which mediates translocation of the toxin’s enzymatic 
components inside the target cell. There is no doubt that the number of related publications on 
biotechnological applications of any of these toxins far exceeds all the residual reports in the 
bionanopore field. At the same time, the reasons why these particular molecules were chosen for 
development are mani-fold. Gramicidin A can serve as an ideal single molecule on/off switch reacting 
to different stimuli and as a sensor for lipid membranes properties. The αHL channel is a structurally 
stable pore, which remains in the electrically low-noise open state over a wide range of experimental 
conditions, including extreme salt concentrations, pH, and temperatures. The crystal structure of αHL 
was solved at a 1.9-Å resolution more than 15 years ago and the protein could be genetically or 
chemically modified in a number of ways. αHL was recently reengineered to form a functional  
bottom-up dimeric pore than spans two adjacent lipid bilayers [335]. On the other hand, when αHL 
was so severely truncated that the protein heptamer could not span a bilayer, the channel insertions 
were still observed, supporting the idea that membrane proteins could stabilize the toroidal lipid  
pores [336]. Interestingly, the channel-forming B component of the anthrax toxin, PA63 is often 
compared with the membrane pore of αHL. This is mostly because these channels were reported to 
form functional mushroom-shaped heptamers. However, electrical characteristics of PA63 differ 
dramatically from those of αHL. First, despite having comparable diameters at the most narrow 
constrictions, the αHL conductance in 1 M KCl solution is ~5 times higher, which allows for a 
significant improvement of the signal-to-noise ratio at the single channel level. Second, since 
formation of the PA63 channels are triggered by the low endosomal pH, the available pH range for the 
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molecular sensing experiments is significantly limited for subacidic pH. Finally, two types of gating 
were reported for the PA63 channels. The typical voltage gating, intrinsic to many β-barrel channels 
incorporated into the artificial bilayers [337,338], shows a pronounced voltage asymmetry in the case 
of PA63 pore, somewhat limiting the voltage range available for the statistically reliable measurements. 
More importantly, the current noise through the open PA63 channel is far from being electrically quiet, 
showing persistent 1/f fluctuations between open and closed states. Similar to αHL, PA63 was shown to 
be able to accommodate βCD molecules. However, the current blockage events were complete, which 
limits the possibilities to use βCD as PA63-modifying adapters. Therefore, it was not the PA63 channel 
of being used as a biosensor per se, but rather an elevated interest in the anthrax toxin and several 
strong research groups working in the field that advanced biotechnological applications for the anthrax 
toxin. Attempting to understand the anthrax toxin uptake mechanism by investigating protein transport 
on the one hand, and the unique ability of reengineered PA63 to deliver enzymatic components inside 
the target tumor cell on the other hand, made this ―noisy‖ channel a nanopore of choice for different 
studies. Some of these reports created directions for the rational modifications of PA63 that could 
significantly alter the pore properties. For instance, F427A PA63 mutant was reported to have ~3-times 
higher conductance than the wild type pore and did not show the wild type PA63’s 1/f noise current 
fluctuations [102,118]. A number of interesting dominant negative [247–250] and predominantly 
octameric PA63 mutants was reported [282]. The anthrax toxin-neutralizing antibodies reconfiguring 
PA into supercomplexes, which are yet to be tested in the bilayer membranes, were also described [339]. 
GrA, αHL, and anthrax toxin’s channel forming component PA63 are available commercially and, in 
contrast to other toxins, for instance epsilon toxin and botulinum neurotoxin, there are no firm biosafety 
restrictions on the usage of small quantities of these proteins under regular laboratory conditions. 
There is no doubt that the nanopore biotechnology is and will remain an exciting field of research. 
In the future, with the development of single-channel electrical recording techniques, X-ray 
crystallography, protein engineering, computational methods, and, importantly, human curiosity, we 
will see many interesting new pore types being explored. As an example, a group of peptide 
phytotoxins produced by Pseudomonas syringae, syringomycin E (SRE), and similar compounds were 
extensively studied by Schagina and colleagues [135,340]. Similarly to gramicidin A, SRE-produced 
pores can be used as sensitive probes of the membrane physical state, surface charge, orientation of 
membrane inner dipoles, and the interaction of membrane-active molecules. 
A cytolytic pore-forming toxin aerolysin of Aeromonas hydrophila represents an interesting 
alterative to αHL. Recently, X-ray crystallography, cryo-EM, MD and computational modeling 
approaches have been used to resolve a near-atomistic structure of the aerolysin pore and to study 
intermediate states leading to the pore formation [341]. Both biosensing and protein translocation 
properties of the channel have been reported [342–345]. Another ―αHL-like‖ oligomeric pore is 
formed by cholesterol-dependent Vibrio cholerae cytolysin [346–348]. Remarkably, the X-ray 
crystallography [349] revealed an interesting structural detail of cytolysin—a narrow constriction 
region formed by an unexpected aromatic tryptophan W318 ring of residues within the pore that is 
otherwise rich in charged amino acid residues. The authors compare this region with the -clamp of 
the B component of the binary bacterial toxins, such as anthrax, where it is believed to be critical for 
the A component’s translocation. At the same time, so far there is no evidence indicating that Vibrio 
cholerae cytolysin serves as a transmembrane protein translocase. We wonder if this structural property 
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could be employed to mimic the Brownian ratchet mechanism of anthrax toxin translocation [239] 
with this significantly different protein in vitro. 
Currently, one of the greatest problems hampering the study of polymer transport and nucleic acid 
pore-assisted sequencing is the high translocation rate of these molecules. Several approaches have 
been developed to slow down the single-molecule transport through a protein nanopore [192,350–352]. 
Thus, genetically optimized porin MspA of Myobacterium smegmatis is believed [19] to be a 
promising pore for biosensing and sequencing applications due to its conical shape providing a very 
narrow (~10-Å) sensing zone [194]. Interestingly, epsilon toxin of Clostridium perfringens (reviewed 
in refs. [353–355]) was reported to form slightly anion-selective stable low-noise pores with a  
single-channel conductance in the range of 440–640 pS in 1 M KCl [356,357]. The polymer-partitioning 
studies to access the epsilon toxin pore’s functional shape and size suggested that the channel is highly 
asymmetric, i.e., conical with the tentative radii of openings of 0.4 and 1.0 nm on the cis and trans 
sides, respectively [358]. However the single channel studies on this channel are limited to three 
publications [356–358], which could be partially explained by lack of the epsilon toxin oligomer’s 
crystal structure and by certain CDC regulations placed on use of this category B agent.  
Besides, the channel-forming B components of the clostridial binary bacterial toxins show 
remarkable structural and functional similarities with PA63 [9,318]. Moreover, PA63 was shown to be 
effective in transporting the His-tagged enzymatic C2I component of the binary C2 toxin into the 
cytosol [359,360]. Along with the anthrax toxin, binary clostridial ADP-ribosylating toxins have been 
examined for their ability to deliver heterologous catalytic domains inside the tumor cells. Many of the 
reported examples, which mainly consist of the chimeric toxins constructed on the basis of the active 
component of C2 toxin, C2I are intensively reviewed elsewhere [9,318]. More recent reports describe 
genetically engineered chimeric C2IN-streptavidin complexes, which were designed to delivered 
biotin-labeled molecules into the cytosol of diverse eukaryotic cell lines by the binding/translocation 
subunit of the toxin [361–363]. The C2-streptavidin delivery system was used to internalize biotin-labeled 
p53 tumor suppressor into different mammalian cell lines, including human tumor cells [364]. The 
direct C2IN-p53 constructs were also investigated [365]. Chemical conjugation strategies as 
alternatives to engineering fusion proteins have also recently been explored resulting in the assembly 
of C2 toxin-based Janus-like supramolecular fusion proteins based on the iminobiotin-avidin linkage 
responding to external stimuli, such as pH [366]. Currently, it is unclear to what extent the  
channel-forming B components of the clostridial binary toxins serve as active translocase of their A 
components, similarly to what is suggested for PA63. On the one hand, the preserved -clamp in 
position 428 was shown to be important for pore formation and for cytotoxicity and rounding up of 
cells by the enzymatic C2I subunits of the C2 toxin [367]. On the other hand, the host cell chaperones 
Hsp90 and the peptidyl-prolyl cis/trans isomerase cyclophilin A were reported to be critical for 
membrane translocation of the active moieties of clostridial C2, iota, and CDT toxins but not for LF of 
the anthrax toxin [368–370]. Provided that the corresponding bilayer measurements show successful 
translocation events similar to those described for the anthrax toxin, we believe these findings would 
add some useful arguments to the anthrax toxin uptake debate [18]. For that purpose, not only the 
native but also the PA63/C2I-His cross-combination of components could be tested.  
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